Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

Summary

Two-hundred and eighty individuals with schizophrenia who have a recent history of violent acts will be randomized in this 2-arm, parallel-group, 24-week, open-label, 7-site clinical trial to examine the effects of treatment with clozapine vs antipsychotic treatment as usual (TAU) for reducing the risk of violent acts in real-world settings

Timeline

Start

2022-03-17

Primary completion

2028-06-30

Completion

2028-12-31

Drugs

Indications